Management of Bacterial Conjunctivitis in Contact Lens Wearers
Immediate Management
- Discontinue contact lens wear immediately at the first sign of redness, pain, tearing, photophobia, blurred vision, discharge, or swelling. The American Academy of Ophthalmology advises prompt removal of lenses when any ocular symptoms appear. 1
- Maintain lens discontinuation until the cornea and conjunctiva have returned to normal appearance and symptoms have fully resolved. This prevents re‑exposure to the infectious environment. 2
- Overnight (extended) lens wear increases the risk of corneal infection approximately five‑fold compared with daily wear. The heightened risk underscores the need for strict wear‑time restrictions. 3
Antibiotic Therapy
- Initiate topical broad‑spectrum antibiotics for bacterial conjunctivitis in contact‑lens wearers. This population requires treatment rather than observation because of the higher likelihood of Gram‑negative pathogens. 4
- Fortified topical antibiotics (e.g., cefazolin + ceftazidime combined with tobramycin or gentamicin) should be used when bacterial keratitis is suspected or confirmed. These regimens provide high‑dose coverage for both Gram‑positive and Gram‑negative organisms. 1
Critical Differential Consideration
- Rule out bacterial keratitis, a vision‑threatening emergency that occurs in up to 30 per 100,000 contact‑lens wearers. Presence of moderate to severe pain or any corneal involvement warrants immediate evaluation for keratitis. 2
Microbiological Considerations
- Gram‑negative organisms, especially Pseudomonas aeruginosa, are more prevalent in infections among contact‑lens wearers. Empiric therapy must therefore include coverage for these pathogens. 4
- Coagulase‑negative Staphylococcus is the most common Gram‑positive isolate in this population. Awareness of the typical flora guides appropriate culture interpretation. 4
- Culture the contact lens and its storage case when available, as they can serve as sources of bacterial contamination. Targeted microbiology assists in tailoring antibiotic therapy. 1
Follow‑Up and Lens Resumption
- Confirm complete resolution of all signs and symptoms before allowing the patient to resume contact‑lens wear. This ensures the ocular surface is fully healed. 2
- Review and modify lens‑care practices prior to resumption, considering options such as daily disposable lenses, high‑oxygen‑permeability materials, or reduced wearing time. Optimizing care reduces future infection risk. 2
- Replace the contact‑lens case routinely every three months. Regular case replacement minimizes microbial colonization. 1
Patient Education and Prevention
- Wash hands with soap and water each time before handling lenses. Hand hygiene is a cornerstone of infection prevention. 1
- Never rinse lenses or their cases with water (tap, bottled, or homemade saline). Water can introduce pathogenic organisms. 1
- Use only fresh disinfecting solution; do not “top off” old solution. Fresh solution maintains adequate antimicrobial activity. 1
- Avoid water exposure while wearing lenses (no swimming, hot tubs, showering, or bathing). Water contact markedly increases infection risk. 1
- Do not sleep in lenses unless the specific lens is approved for extended wear. Sleeping in non‑approved lenses elevates the chance of corneal infection. 1
Avoiding Recurrence
- Do not resume lens wear prematurely, as early reuse can lead to recurrent or chronic conjunctivitis. Proper timing of lens re‑initiation is essential for sustained recovery. 2
- Do not overlook bacterial keratitis; if suspected, initiate more aggressive treatment than for simple conjunctivitis. Early recognition and treatment prevent vision loss. 1
Management of Mild Bacterial Conjunctivitis in Contact Lens Wearers
Diagnosis – Distinguishing Simple Conjunctivitis from Bacterial Keratitis
Antibiotic Selection – Preference for Fluoroquinolones
Inadequate Alternatives
Initial Treatment Regimen for Mild Cases
Criteria for Escalation to Fortified Antibiotics
Microbiological Considerations & Resistance Patterns
Contact Lens Management
Follow‑Up and Monitoring
Evidence strength for the above recommendations is not explicitly stated in the source material.